buyWeak
Sandra Milligan bought $50k of GOSS
director at Gossamer Bio, Inc.. 26,050 shares at an average of $1.92, traded Aug 19, 2025, filed Aug 20, 2025.
Conviction score
32Value
$50k
26,050 shares
Holdings after
58,050
+81% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +7Trade size$50k at market
- +10Relative to holdingsHoldings up 81%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001728117-25-000072, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 19, 2025 | POpen-market purchase Common Stock | +26,050 | $1.92 | $50k | 58,050 | Aug 20, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.